# Nuclide record spotlight (trial). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/trials/spotlight/>
  a schema:MedicalTrial ;
  nuclide:kind "trial" ;
  schema:identifier "spotlight", "NCT04186845" ;
  schema:name "SPOTLIGHT"@en ;
  schema:alternateName "18F-rhPSMA-7.3 biochemical recurrence trial"@en ;
  schema:description "A PET scan (the tracer later approved as Posluma) was tested in men whose PSA rose again after treatment for prostate cancer, to see how often it can find exactly where the cancer has come back."@en ;
  schema:url <https://nuclide.cc/trials/spotlight/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/37126069/>, <https://clinicaltrials.gov/study/NCT04186845> ;
  nuclide:status "completed" ;
  nuclide:tag "diagnostic trial", "prostate cancer", "biochemical recurrence" ;
  nuclide:phase "3" ;
  nuclide:related <https://nuclide.cc/drugs/flotufolastat/>, <https://nuclide.cc/technologies/psma-pet/>, <https://nuclide.cc/indications/prostate-bcr/>, <https://nuclide.cc/companies/blue-earth-diagnostics/>, <https://nuclide.cc/trials/lighthouse/>, <https://nuclide.cc/isotopes/f-18/> .